Posted on

Two Drug ART? — Clinical Considerations

In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Podcast (ehiv): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

Emerging Promises and Challenges with the Use of Antiretroviral Therapy for Prevention of HIV Transmission

Volume 1, Issue 12.

Dr. Kenneth H. Mayer from Harvard discusses the important issues related to Pre-Exposure Prophylaxis (PrEP) in HIV-uninfected individuals at high-risk and reviews the results of several key studies that evaluated the use of PrEP.

Podcast (ehiv): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

Occult Hepatitis B Virus Infection

Volume 2, Issue 6.

Dr. Kennenth Sherman, Gould Professor of Medicine and Director of the Division of Digestive Disease at the University of Cincinnati College of Medicine will diferentiate how occult HBV differs from classical HBV infections.

Podcast (eviralhepatitis): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS